<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-108107</identifier>
<setSpec>0213-9626</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Autoantibodies in serum of patients with chronic prostatitits/chronic pelvic pain syndrome</dc:title>
<dc:description xml:lang="en">Introduction: Chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS) is an inflammatory condition that affects the prostate gland without evidence of infection in the urinary tract. Evidence reported during last decade supports a role for an autoimmune response to prostate antigens as a cause of this pathology. In fact, the presence of a specific cellular immune response against prostate antigens was demonstrated inCP/CPPS patients, but little is known about the humoral immune response. Therefore, we decided to study the presence of serum specific antibodies to prostate antigens, expressed in the human prostatic cell line DU-145, and other serum autoantibodies that are markers of different autoimmune diseases. Materials and Methods: 25 patients with CP/CPPS and 13 normal controls were studied and underwent the determination of serum antibodies anti-DU-145 cells, Rheumatoid Factor (..) (AU)</dc:description>
<dc:creator>Virginia Ferrero, Paola</dc:creator>
<dc:creator>Darío Motrich, Rubén</dc:creator>
<dc:creator>Elena Rivero, Virginia</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: La prostatitis crónica/síndrome de dolor pélvico crónico(CP/CPPS) se presenta como una inflamación de la próstata sin evidencia de infección del tracto urinario. Algunos autores postulan a la respuesta autoinmune como causa de esta patología. Aunque se ha demostrado la presencia de respuesta inmune celular específica contra antígenos prostáticos, poco se conoce acerca de la respuesta inmune humoral. Es por ello que decidimos estudiar la presencia de autoanticuerpos séricos específicos de antígenos prostáticos, expresados en la línea celular prostática humana DU-145, y de otros autoanticuerpos séricos (..) (AU)</dc:description>
<dc:source>Inmunología (1987);27(4): 167-175, oct.-dic. 2008. tab</dc:source>
<dc:identifier>ibc-108107</dc:identifier>
<dc:title xml:lang="es">Autoanticuerpos séricos en pacientes con prostatitis crónica/ síndrome de dolor pélvico crónico</dc:title>
<dc:subject>^d7426^s22038</dc:subject>
<dc:subject>^d24529^s22038</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1329^s22038</dc:subject>
<dc:subject>^d32175^s22038</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d11915^s22038</dc:subject>
<dc:subject>^d31202^s22038</dc:subject>
<dc:subject>^d28563</dc:subject>
<dc:type>article</dc:type>
<dc:date>200812</dc:date>
</metadata>
</record>
</ibecs-document>
